Publication Topic

Chia VM, Lowe KA, O’Malley CD, Kelsh MA, Taylor A, Mowat F, et al. An updated assessment of global ovarian cancer trends. Presented at International Gynecological Cancer Society Annual Meetings, Vancouver, Canada, October 13–16, 2012.

Mitchell M, Taylor A, Lowe K, Langeberg W, Alexander D, Kelsh M, et al. Breast cancer bone metastasis prevalence and survival outcomes: A quantitative review of the literature. Presented at the 34th Annual San Antonio Breast Cancer Symposium, San Antonio, TX, December 6–10, 2011.

Lau EC, Mowat FS, Kelsh MA, Legg JC, Engel-Nitz NM, Watson HN, Collins HN, Nordyke RJ, et al. 2011. Use of electronic medical records (EMR) for oncology outcomes research: Assessing the comparability of EMR information to patient registry and health claims data. Clin Epidemiol 3(1):259–272; doi: 10.2147/CLEP.S23690. PMID: 22135501.

Mitchell M, Taylor A, Lowe K, Langeberg W, Alexander D, Kelsh M, et al. Prevalence of bone metastasis after breast, lung, and prostate cancers: A systematic and quantitative review of the literature. Presented at the 27th Annual Meetings of International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Chicago, IL, August 14–17, 2011.

Lau EC, Steffey D, Legg JC, Watson HN, Mowat FS, Kelsh MA. The problem of missing data: Using imputation methods to facilitate oncology outcomes research. Presented at the 27th Annual Meetings of International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Chicago, IL, August 14–17, 2011.

Taylor A, Kanas G, Primrose JN, Langeberg WJ, Alexander DD, Kelsh MA, et al. Survival after surgical resection of hepatic metastases from colorectal cancer: An updated review and meta-analysis. Presented at 13th World Congress on Gastrointestinal Cancer, Barcelona Spain, June 22–25, 2011.

Kelsh MA, Kucera G, Erdreich L. Meta-analysis of acoustic neuroma and mobile phone use. Presented at BEMS 33rd Annual Meetings, Halifax, Canada, June 12–17, 2011.

Haws L, Proctor D, Thompson C, Harris M. Research plan to fill data gaps in the mode of action for cancer risk assessment of hexavalent chromium in drinking water. Presented at  Society of Toxicology 50th Annual Meeting, Washington, DC, March 2011.

Proctor D, Haws L, Thompson C, Harris M. 2011. Use of mode of action and pharmacokinetics to inform the cancer risk assessment of ingested Cr(VI): A case study. Presented at the Society of Toxicology 50th Annual Meeting, Washington, DC, March 2011.

Thompson CM, Grafström RC. 2011. Considerations for the implausibility of leukemia induction by formaldehyde. Toxicol Sci 120(1):230-232; doi: 10.1093/toxsci/kfq340. PMID: 21059796.

Proctor D, Meek B. Using mode of action data to guide quantitative cancer risk assessment: A case study of hexavalent chromium in drinking water. Presented at Society of Toxicology 50th Annual Meeting, Washington, DC, March 2011.

Kelsh MA, Alexander DD, Mink PJ, Mandel JH. 2010. Occupational trichloroethylene exposure and kidney cancer: A meta-analysis. Epidemiology 21(1):95–102; doi: 10.1097/EDE.0b013e3181c30e92. PMID: 20010212.

Gatto NM, Kelsh MA, Mai DH, Suh M, Proctor DM. 2010. Occupational exposure to hexavalent chromium and cancers of the gastrointestinal tract: A meta-analysis. Cancer Epidemiol 34(4):388-399; doi: 10.1016/j.canep.2010.03.013. PMID: 20430714.

Urban JD, Tachovsky JA, Haws LC, Staskal DF, Harris MA. 2010. Response to Buchanan et al.’s comment on Urban et al. “Assessment of Human Health Risks Posed by Consumption of Fish from the Lower Passaic River, New Jersey.” Sci Tot Environ 408(8):2004-2007; doi: 10.1016/j.scitotenv.2010.01.046.

Thompson CM, Grafstrom RC. 2009. Commentary: Mechanistic considerations for associations between formaldehyde exposure and nasopharyngeal carcinoma. Environ Health 8:53; doi: 10.1186/1476-069X-8-53. PMID: 19939253.

Lea IA, Jackson MA, Dunnick JK. 2009. Genetic pathways to colorectal cancer. Mutat Res 670(1–2):96–98; doi: 10.1016/j.mrfmmm.2009.06.011. PMID: 19576232.

Staskal-Wikoff DF, Harris MA, Haws LC, Birnbaum LS, Tachovsky JA. Probabilistic evaluation of cancer and non-cancer risk associated with exposure to BDE 209 in automobiles. Presented at Dioxin 2009, Beijing, China, 2009.

Elespuru RK, Agarwal R, Atrakchi A, Bigger CAH, Heflich RH, Jagannath D, Levy DD…Robison TW, et al. 2009. Current and future application of genetic toxicity assays: The role and value of in vitro mammalian assays. Toxicol Sci 109(2):172-179; doi: 10.1093/toxsci/kfp067. PMID: 19336498.

Gatto N, Kelsh M, HaMai D, Suh M, Proctor D. A meta-analysis of the relationship between occupational exposure to hexavalent chromium and cancers of the gastrointestinal tract. Society of Toxicology 48th Annual Meeting, Baltimore, MD, March 2009.

Kelsh MA, Morimoto L, Lau E. 2009. Cancer mortality and oil production in the Amazon region of Ecuador. Int Arch Occup Environ Health 82(3):381–395; doi: 10.1007/s00420-008-0345-x. PMID: 18651161.